Nestlé’s $70 billion infant nutrition business faces twin pressures on sugar and safety
Nestlé’s $70 billion infant nutrition business faces twin pressures on sugar and safety is drawing significant interest across the industry.
Nestlé India confirmed in January that their products are not affected by the global recall of certain infant formula batches due to potential Bacillus cereus contamination. They clarified that all infant formula sold in India is produced locally and complies with FSSAI regulations.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Marico signs pact to buy majority stake in Vietnamese D2C company Skinetiq
- PM Modi to participate in groundbreaking event of HCL
- Rashmika Mandanna’s temple jewellery sets 2026 bridal goals: Here’s how to recreate her look with budget-friendly picks
- Who Loses Tax Exemption on Disability Pension? Budget 2026 Sparks Debate
Source: Original →